Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[Oruka Therapeutics, Inc. Common Stock](/topic/$orka)

### Sentiment: XXX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$orka/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$orka/time-series/sentiment.tsv)  
**Current Value**: XXX%  
**Daily Average**: XX%  
**1 Week**: XXX% no change  
**1 Month**: XXX% +15%  
**6 Months**: XXX% +24%  
**1 Year**: XXX% +50%  
**1-Year High**: XXX% on 2024-10-20  
**1-Year Low**: XX% on 2025-01-16  

**Most Supportive Themes**
- **Positive Biotech News:** (40%) Posts highlight positive news such as IND clearance and upcoming trials for Oruka Therapeutics.
- **Company Mentions and Comparisons:** (30%) Posts mention Oruka Therapeutics in the context of other biotech companies, often in positive comparisons or watchlists.
  
**Most Critical Themes**
- **Market and Portfolio Adjustments:** (15%)  Some posts discuss portfolio adjustments and decreases in holdings of ORKA, indicating potential concerns.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %  | Negative | %  |
| ------- | -------- | -   | ------- | -  | -------- | -  |
| X       | XXX      | XX% | X       | X% | X        | X% |
|         |          |     |         |    |          |    |
| Total   | XXX      | XX% | X       | X% | X        | X% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Oruka Therapeutics, Inc. Common Stock

Sentiment: XXX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XXX% +15%
6 Months: XXX% +24%
1 Year: XXX% +50%
1-Year High: XXX% on 2024-10-20
1-Year Low: XX% on 2025-01-16

Most Supportive Themes

  • Positive Biotech News: (40%) Posts highlight positive news such as IND clearance and upcoming trials for Oruka Therapeutics.
  • Company Mentions and Comparisons: (30%) Posts mention Oruka Therapeutics in the context of other biotech companies, often in positive comparisons or watchlists.

Most Critical Themes

  • Market and Portfolio Adjustments: (15%) Some posts discuss portfolio adjustments and decreases in holdings of ORKA, indicating potential concerns.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXX XX% X X% X X%
Total XXX XX% X X% X X%
Oruka Therapeutics, Inc. Common Stock (ORKA) Sentiment
/topic/$orka/sentiment